RxDoctor Payments Data

James Doran, MD

Orthopaedic Surgery · Somers Point, NJNPI 1992182612

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (43.0%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Arthrex at 47.5% of the total. Reporting peaked in 2021 at $9,544 and has fallen 97.9% since, to $205 in 2025.

$14,653in general payments, 2019–2025

Across 100 payments — averaging $146.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$7K
  • Medical Device Business Services, Inc.$3K
  • Liberty Surgical Inc.$2K
  • Stryker$1K
  • Johnson & Johnson$654
  • Eclipse Technology Solutions Inc.$142
  • plus $333 from 8 others

What the payments were for

  • Grants$2,40216%
  • Travel & lodging$2,61818%
  • Food & beverage$3,33423%
  • Education$6,30043%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,653 in reported general payments places this provider in the 75th percentile of 587 orthopaedic surgery providers in New Jersey.

See all orthopaedic surgery providers in New Jersey →

Medicare billing

Part B allowed, 2024
$239,379
Medicare patients
324
Services billed
8,428

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Methylprednisolone79$561
Ibuprofen72$560
Celecoxib13$468
Diclofenac Sodium16$338
Cyclobenzaprine Hcl52$252
Naproxen20$185
Meloxicam35$105

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Somers Point

See the full list for New Jersey →

Where these figures come from

Is this you, or does something look wrong? →